Location History:
- Los Angeles, CA (US) (2007)
- Seattle, WA (US) (2011)
Company Filing History:
Years Active: 2007-2011
Title: Shon Lee Crampton: Innovator in Pharmaceutical Protein Technologies
Introduction
Shon Lee Crampton is a notable inventor based in Seattle, WA, who has made significant contributions to the field of pharmaceutical proteins. With a total of two patents to his name, Crampton's work focuses on enhancing the efficiency and effectiveness of protein formulations.
Latest Patents
Crampton's latest patents include "Concentrated protein lyophilates, methods, and uses." This invention provides lyophilized compositions of high surface area that comprise a protein, which reconstitute quickly and efficiently to a solution of high protein concentration. The invention minimizes the formation of foam, effervescence, bubbles, turbidity, or particulates that could be harmful. Additionally, it offers methods for creating these lyophilized compositions and introduces Raman Imaging Spectrographic methods for real-time analyses of polymorphs in a sample using PLS algorithms. Another significant patent is "Crystals of etanercept and methods of making thereof." This invention relates to crystalline etanercept, methods for its production, pharmaceutical compositions containing it, and therapeutic uses of such compositions.
Career Highlights
Crampton is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to focus on developing advanced protein formulations that have the potential to improve patient outcomes.
Collaborations
Crampton has collaborated with notable colleagues, including Timothy David Osslund and Christi L Clogston. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Shon Lee Crampton is a distinguished inventor whose work in pharmaceutical protein technologies has the potential to revolutionize the field. His innovative patents and contributions to Amgen Inc. highlight his commitment to improving healthcare solutions.